Efficient methods for signal detection from correlated adverse events in clinical trials
DOI10.1111/BIOM.13031zbMATH Open1436.62539OpenAlexW2912429205WikidataQ91253116 ScholiaQ91253116MaRDI QIDQ5214577FDOQ5214577
Authors:
Publication date: 7 February 2020
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.13031
Recommendations
- Detecting potential safety issues in clinical trials by Bayesian screening
- Accounting for multiplicity in the evaluation of ``signals obtained by data mining from spontaneous report adverse event databases
- A likelihood ratio test based method for signal detection with application to FDA's drug safety data
- A study of speedier signal detection for serious adverse events
- Likelihood-ratio-test methods for drug safety signal detection from multiple clinical datasets
Applications of statistics to biology and medical sciences; meta analysis (62P10) Measures of association (correlation, canonical correlation, etc.) (62H20) Signal theory (characterization, reconstruction, filtering, etc.) (94A12) Detection theory in information and communication theory (94A13)
Cited In (4)
- Likelihood-ratio-test methods for drug safety signal detection from multiple clinical datasets
- Detecting potential safety issues in clinical trials by Bayesian screening
- Bayesian approach for clinical trial safety data using an Ising prior
- A study of speedier signal detection for serious adverse events
This page was built for publication: Efficient methods for signal detection from correlated adverse events in clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5214577)